Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
Stock Group : Switch Group:
Group's Momentum :
Today's Momentum
Up 3
Down 7   
Unchange 18
Average +0.83%
Historial Performances
5 Days2.48%
1 Month6.31%
3 Months8.07%
6 Months44.30%
YTD169.63%
52 Weeks169.52%
News And Links For The Group (Contribute a link)
[CELG]   3 Small-Cap Biotech Stocks to Buy This Fall  (Motley Fool)   21-Sep-17 07:47
[CELG]   3 Stocks That Put Coca-Cola's Returns to Shame  (Motley Fool)   20-Sep-17 08:25
[MNKD]   Believe It or Not, MannKind Is Now One of the Hottest Biotech Stocks on the Market  (Motley Fool)   20-Sep-17 07:18
[AMGN, CELG]   Biotech And Pharma Stocks To Soak Up At The Bottom  (Seeking Alpha)   19-Sep-17 12:29
[AMGN]   Amgen and Allergan: Avastin Biosimilar Approval Part 2  (Seeking Alpha)   19-Sep-17 09:41
[CELG]   These 3 Biotech Stocks Just Hit 52-Week Highs: Are They Buys?  (Motley Fool)   19-Sep-17 07:31
[AMGN]   3 Great Income Stocks That Could Double Their Dividends  (Motley Fool)   17-Sep-17 12:17
[CELG]   Don't Make This Huge Mistake With Celgene   (Motley Fool)   17-Sep-17 09:18
[CELG]   Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?  (Motley Fool)   16-Sep-17 08:03
[CELG, AMGN]   3 Reasons Why Gilead Sciences Stock Is a Buy Now  (Motley Fool)   15-Sep-17 07:45
[AMGN]   A Biosimilar Cure for Sky-High Cancer Drug Prices  (Motley Fool)   14-Sep-17 21:30
[MBRX]   Moleculin Engages CRO to Begin Clinical Trials of WP1220 for the Treatment of Cutaneous T-Cell Lymphoma  (Marketwire)   13-Sep-17 07:30
[AMGN]   5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing  (Motley Fool)   13-Sep-17 06:38
[AMGN]   3 Things Amgen Inc.'s Management Just Said That You'll Want to Know  (Motley Fool)   12-Sep-17 15:33
[AMGN]   5 Things Regeneron's CEO Said as the Biotech Stock Sank  (Motley Fool)   12-Sep-17 06:48
[CELG]   3 Growth Stocks to Hold for 50 Years  (Motley Fool)   12-Sep-17 06:04
[CELG]   3 Reasons to Buy Allergan plc Stock Right Now  (Motley Fool)   10-Sep-17 08:33
[MNKD]   MannKind - Afrezza Scripts Finish August Flat  (Seeking Alpha)   9-Sep-17 09:47
[CELG]   Biotech Bonanza: A Key Piece Falls In Place  (Seeking Alpha)   7-Sep-17 14:51
[CELG]   5 Things You'll Want to Know From Celgene Corporation's Latest Presentation  (Motley Fool)   7-Sep-17 07:47
==>More News
Daily Top/Bottom Performancers
symbol last  change  % change
CYCC 2.2401 0.3951 +21.41%
MBRX 2.50 0.1 +4.17%
CERS 2.61 0.09 +3.57%
MIPI N/A N/A 0%
IMCL 0.159277 +0.000000 0%
IDMI N/A N/A 0%
NEOL N/A N/A 0%
PGLA N/A +0 0%
ZGEN N/A N/A 0%
OXGN 0.70 +0.00 0%
......
Full List For Daily Performance
......
DNA N/A N/A 0%
AFFY 0.04775 +0.00000 0%
CEGE N/A N/A 0%
CELG 143.78 0.46 -0.32%
CYTK 14.20 0.05 -0.35%
SNSS 2.0299 0.0101 -0.49%
INGN 102.87 0.71 -0.69%
AMGN 186.64 1.53 -0.81%
ZIOP 6.06 0.06 -0.98%
MNKD 1.94 0.04 -2.02%
Latest Group's Insider Trading
Ticker Tran Shares Price Reported
INGN sell 14,000 $102.30 19-Sep-17 17:23
CELG sell 9,250 $141.56 14-Sep-17 16:35
INGN sell 2,500 $103.23 12-Sep-17 18:19
CYTK sell 10,131 $14.60 8-Sep-17 16:48
CYTK sell 100 $15.00 8-Sep-17 16:48
INGN sell 2,500 $97.44 8-Sep-17 13:20
CELG sell 9,250 $139.03 6-Sep-17 18:53
CYTK sell 5,000 $14.71 1-Sep-17 19:21
==>More & Details
Real-time SEC Filings For the Group
symbol Filing Type Filing Time
ENMD420-Sep-17 17:00
CYTK8-K19-Sep-17 17:00
ENMD418-Sep-17 18:51
CELG414-Sep-17 16:35
CYCC8-K11-Sep-17 17:22
MNKD8-K11-Sep-17 08:31
OXGNFWP11-Sep-17 08:30
CYTK48-Sep-17 16:48
CYTK48-Sep-17 16:48
AMGNCT ORDER8-Sep-17 10:09
ENMD8-K7-Sep-17 16:34
CELG46-Sep-17 18:53
MNKD8-K6-Sep-17 16:30
CYTK41-Sep-17 19:21
CELGSC 13G1-Sep-17 06:09
CERS431-Aug-17 18:14
CELG431-Aug-17 16:03
CYTK430-Aug-17 19:29
CYTK430-Aug-17 19:29
MNKD429-Aug-17 21:08
Earning Calendar Summary
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*